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ABSTRACT 
A third of healthcare spending in the United States is considered waste, and costs are growing at 
an unsustainable rate. Reducing unnecessary cardiac telemetry, a costly intervention with a high 
potential for overuse, may be an opportunity to reduce waste. We performed a review of 250 
consecutive patients admitted to telemetry capable beds on the general medical-surgical, 
noncritical care units. Based on the American Heart Association Practice Standards for 
Electrocardiographic Monitoring in Hospital Settings, appropriateness of telemetric monitoring 
during each inpatient day was assessed, with identification of significant new arrhythmias, code 
calls, and clinical decisions resulting from telemetry. Cost of a telemetry day was calculated 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
Page 2 of 10 
 
using a time-driven activity-based cost model. Patients (63±19 years, 54% male) spent a total of 
1640 days hospitalized, 1399 (85%) of which were on telemetry. Average length of stay was 6.6 
days, and average telemetry time was 5.6 days. Only 334 (24%) telemetry days were deemed 
appropriate based on Practice Standards. During telemetric monitoring, 16 new significant 
arrhythmias were detected, 4 code calls were made, and 19 significant clinical decisions were 
prompted by telemetry. No cardiac code call occurred on a nontelemetry day. The cost of 
telemetry was calculated as $34.28 more per day than a nontelemetry hospital day. Elimination 
of inappropriate telemetry days would result in a minimum estimated savings of $37,007 in these 
250 patients, and an annual savings of $528,241 overall. Telemetric monitoring is frequently 
overused. In conclusion, our findings propose that a reduction in inappropriate telemetry days in 
accordance with the American Heart Association Practice Standards could result in significant 
cost savings. 
 
Key Words: cardiac telemetry, quality improvement, time-driven activity based costing 
 Healthcare costs in the United States now account for 18% of the gross domestic product, and 
per capita spending is approximately twice that of other major industrialized nations without 
demonstrating better health outcomes.
1
 A significant opportunity for reducing healthcare costs is 
reducing waste, accounting for up to one-third of healthcare expenditures.
1
 Cardiac telemetry is 
widely used in hospitals to detect clinically significant arrhythmias.
2
 Its use has increased 
substantially since its invention, especially in noncritical care settings, due to increased 
availability and portability of telemetry monitoring systems.
2 
Practice standards for the use of 
telemetry were published in 1991 by the American College of Cardiology due to concerns of 
overuse
 
and most recently updated by the American Heart Association in 2004.
3,4
 Previous 
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observational investigations of appropriate use of telemetry appraised cost of telemetry at 
between $53 and $1400 per day.
2,5,6,7
 Previous cost models for daily telemetry usage focused on 
nursing full-time equivalents associated with telemetry monitoring, equipment costs and/or 
downstream costs with associated flow bottlenecks and backups.
5
  Our study evaluated the 
appropriateness of telemetry use at a tertiary care hospital, and used a time-driven activity-based 
costing model to estimate the potential cost savings that could be realized through optimal use of 
telemetry. 
Methods 
This study was approved by the Ochsner Clinic Foundation Internal Review Board. A 
query of our 432-bed tertiary care hospital’s electronic medical record identified 250 sequential 
inpatients monitored using cardiac telemetry during their stay. Patients in intensive care and 
coronary care units were excluded as they undergo telemetric monitoring based on mandates 
from the Joint Commission. General cardiology units were also excluded because a majority of 
these patients are admitted for conditions that are indications for telemetry based on the 2004 
American Heart Association guidelines.
4
 The cardiothoracic step-down unit was also excluded, 
as recent major cardiac surgery is an indication for telemetry, again based on the 2004 
guidelines.  
Two physicians performed a retrospective chart review of all 250 admissions. 
Appropriateness or inappropriateness of telemetry initiation was assessed based on the admitting 
teams progress note from the day that telemetry was initiated. Duration of telemetry was deemed 
appropriate or inappropriate based on continuance or resolution of the indications for telemetry 
(see Table 1), based on progress notes, associated diagnoses and diagnostic studies. All “rapid-
response” and code calls were identified from standardized rapid-response and code 
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documentation. Clinical decisions motivated by telemetry findings were identified as therapeutic 
decisions (e.g., medication initiation or changes, cardiology consults, or procedures) documented 
in provider notes. 
The primary end point was appropriateness of telemetric monitoring for each day of 
telemetry use. Secondary end-points were treatment changes that were made based on telemetric 
data, and the initiation of rapid response/code calls (and whether these occurred on appropriate 
telemetry days or inappropriate telemetry days).  
Using a time-driven activity-based costing model, we estimated the incremental cost of a 
telemetry day based on a number of fixed costs and variable costs. Time-driven activity-based 
costing analysis is a method of assigning cost rates to various resources consumed by proving 
insight into processes and costs that conventional healthcare costing systems are unable to 
estimate.
8,9
 This is accomplished by mapping the processes related to an activity and identifying 
the resources involved at each step. Time required is estimated for each process step, and the 
associated cost is estimated by determining the amount of time the total process takes and the 
cost of the resources (personnel and/or equipment) involved in the processes.  
For our study, we calculated the cost of each significant telemetry event by determining 
the process by which a telemetry event is investigated and reported, along with all of the 
personnel associated with each event. The time required for each step in the process was 
determined by direct observation of clinicians involved in the investigation and reporting of a 
telemetry event. The total time required for each employee was recorded over 50 telemetry 
events. The estimated incremental cost of unnecessary telemetric monitoring was derived from 
this result – first for these 250 patients and then extrapolated to the entire hospital for an entire 
year. Thus, telemetry cost per day was calculated as summarized in Figure 1. 
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Results 
We reviewed 250 admissions. Patient characteristics are summarized in Table 2. Patients 
were admitted for a total of 1640 hospital days (median 4 days [interquartile range: 3-6 days]) 
with cardiac telemetry used on 1399 (85%) days (median 3 days [interquartile range: 2-5 days]). 
The appropriateness of telemetric monitoring based on guidelines, and the associated 
outcomes, are summarized in Table 3. Of the 16 significant arrhythmias detected, all were 
recorded during appropriate telemetry days, while none was recorded on an inappropriate 
telemetry day. All 5 code calls were due to respiratory arrest with 4 being on appropriate 
telemetry days and 1 on an inappropriate telemetry day. There were 18 significant clinical 
decisions motivated by telemetry findings during appropriate telemetry days, with only 1 such 
decision made on an inappropriate telemetry day.  
There were 7 days during which a patient had guideline-based indication(s) for telemetry 
but telemetric monitoring was either not initiated or had been removed prematurely. No critical 
event or significant clinical decision occurred on these non-telemetry days.  
Based on our time-driven activity-based costing model (Figure 2) and a standard linear 
depreciation model for central and portable telemetry monitoring equipment, the calculated cost 
of a telemetry day was $34.31 more than a non-telemetry day. The calculation equation and cost 
bases are shown in Figure 1 and are unique to our institution. 
Elimination of inappropriate telemetry days could have resulted in a conservatively-
estimated savings of $36,540 for these 250 patients, and for the entire hospital population an 
annual savings of $528,648.  
Discussion 
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Our study has several important findings. First, the majority of cardiac telemetry 
monitoring at our institution is inappropriate based on the 2004 American Heart Association 
(AHA)/ American College of Cardiology (ACC) guidelines. In addition, there is little benefit to 
telemetry overuse, as no clinically significant arrhythmia nor code call occurred on inappropriate 
telemetry days. Finally, optimization of telemetry utilization, primarily through reduction in 
inappropriate use, could result in significant cost savings. 
Cardiac telemetry, when used in the correct setting, is a useful tool for identifying 
clinically significant arrhythmias. Our study shows that the majority of telemetry days at our 
hospital are inappropriate based on the 2004 AHA/ACC guidelines for inpatient cardiac 
telemetry monitoring, which are the most recent guidelines despite being more than a decade old 
at the time of our study. This proportion of inappropriate telemetry days far exceeded that of a 
similar study performed by Benjamin et al.
5
 Potential reasons for telemetry overuse include lack 
of awareness of the AHA/ACC guidelines, non-adherence to these guidelines, lack of provider 
awareness of ongoing telemetry use and a lack of telemetry auditing. These causes have been 
described in previous studies and should be a target for future study and intervention.
2,5,6,7,10
 
Our analysis of inappropriate telemetry days found that monitoring on inappropriate days 
provided little clinical information and resulted in few if any significant clinical decisions. There 
was no code call of cardiac origin on an inappropriate telemetry day. Therefore, on inappropriate 
telemetry days, if telemetry were not used, no adverse events would have been missed.  
In addition, there were a number of days during which patients “should” have been on 
telemetry based on guideline-directed indications, but telemetry was not used or had been 
prematurely discontinued. Fortunately, no adverse events occurred on these days. Thus, in 
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addition to inappropriate/wasteful telemetry use for patients who did not require monitoring, 
there was failure to identify patients with guideline-directed indications for telemetry monitoring. 
There is evidence that up to one-third of money spent on medical care in the US is 
waste.
1
 If we are to continue to provide a financially tenable health system, it is incumbent upon 
us to reduce waste. Based on our conservative estimate of $528,241 saved per year via reduction 
of inappropriate telemetry at our hospital, similar waste reduction at a medium-sized community 
hospital with 175 telemetry-capable beds could translate to annual cost savings of $213,986. Due 
to the immense opportunity for substantial cost savings, all hospitals, regardless of size and 
capability, should make a concerted effort to reduce inappropriate telemetry use. Tools for such 
optimization could include clinician education regarding practice standards for cardiac telemetry 
monitoring, clinical decision support tools embedded within the electronic medical record, and 
electronic medical record-based protocolization of telemetry monitoring.
7 
 
Since this was a retrospective chart review, the quality of our data relies on the quality of 
documentation by the provider teams. Diagnostic studies (such as ECGs and labs) and associated 
diagnoses were analyzed to further determine if telemetry was indeed appropriate. Additionally, 
our daily telemetry cost calculation likely underestimates the true cost of telemetry, since 
downstream effects, such as decreased emergency department throughput due to reduced 
availability of inpatient telemetry beds, the cost of unnecessary consultations from telemetry 
overuse, and other unaccounted effects, were not included. Due to wide variation in provider 
salaries (trainees vs. medical staff vs. mid-level providers), cost related to their work time was 
not incorporated into our time-driven activity-based costing model (further underestimating 
cost). Further prospective studies with protocolization of telemetry and robust cost data are 
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needed to provide greater insight into the exact magnitude of cost savings that would result from 
optimized telemetry use. 
Telemetric monitoring is frequently overused among patients admitted to non-cardiac, 
non-critical care services. A reduction in inappropriate telemetry days in accordance with the 
American Heart Association Practice Standards would result in significant savings without 
missing clinically significant events. 
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Figure 1: Telemetry cost per day calculation equation and cost bases for calculation  
Figure 2: Telemetry event reporting workflow  
Table 1: Indications for Cardiac Telemetry Adapted from 2004 AHA Practice Standards and 
1991 ACC Guidelines.
3,4
 
Indication for Monitoring Suggested Time Frame 
1. Patients with chest pain syndromes  12-24 hours or negative biomarkers  
2. Patients receiving anti-arrhythmics or medication 
adjustments for rate control of chronic atrial 
tachyarrhythmia 
24 hours or until definitive management 
3. Patients being evaluated for syncope  24-48 h  
4. DNR Patients with symptomatic arrhythmias  Until optimal rhythm management is achieved 
5. Assessment, monitoring and control of significant 
arrhythmias (Supraventricular or ventricular 
tachycardia, bradycardia) that require medical 
therapy
 
 
72 hours 
6. New onset atrial fibrillation with or without rapid 
ventricular response 
Until optimal rate/rhythm management or 24h after 
successful cardioversion 
7. Patient started on drug known to cause torsades 
de pointes   
72 hours, stable dosage or until drug is discontinued  
8. Patients who have severe electrolyte 
abnormalities 
24 hours or until stabilization of electrolyte 
derangement and no QT related arrhythmias  
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9. Assessment and monitoring of patients with drug 
or chemical toxicity known to cause cardiac 
arrhythmias  
Until drug is excreted/metabolized and late effects 
have resolved 
10. Newly diagnosed stroke 24 hours  
11. Patients with other acute neurological events  24 hours or until hemodynamically stable  
12. Patients with significant cardiovascular disease 
history admitted with pneumonia, severe asthma 
or COPD exacerbation associated with 
tachycardia or significant hypoxemia not 
requiring ICU level care
 
 
During acute phase of illness 
13. Variceal bleeding treated with endoscopy, 
sclerotherapy and intravenous vasopressin
 
 
Until bleeding risk is stratified and treated or after 3 
days of clinical stability 
14. Major non-cardiac surgery with prior CAD or 
CAD risk factors
 
 
24 hours or until hemodynamically stable 
15. Following sedation or anesthesia for procedures  Until patient is awake, alert and hemodynamically 
stable 
16. Drug overdose or active alcohol withdrawal  24 hours 
Table 2: Patient Characteristics (n=250) 
Table 3: 
Telemetry 
Monitoring 
Appropriateness 
and Significant 
Clinical Events 
 
 
Mean Age (Years) 62.6  
Men 54.0 
Average LOS (days) 6.6  
Average Days on Telemetry  5.6 
Prior Coronary Artery Disease  26.0% 
Prior Congestive Heart Failure  25.2% 
Type 2 Diabetes Mellitus  29.6% 
Atrial Fibrillation  17.2% 
Most Common Admitting Diagnoses 
Pneumonia 
Sepsis 
Stroke 
 
23% 
18% 
14% 
Appropriate Telemetry Days 334 (23.8%) 
Inappropriate Telemetry Days  1065 (76.5%) 
Arrhythmias on Appropriate Telemetry Day 16 (100%) 
Arrhythmias on Inappropriate Telemetry Day 0 (0%) 
Code Calls on Appropriate Telemetry Day 4 (80%) 
Code Calls on Inappropriate Telemetry Day 1 (20%) 
Clinical Decisions on Appropriate Telemetry Day 18 (94.7%) 
Clinical Decisions on Inappropriate Telemetry Day 1 (5.3%) 
